BRIEF-Progenics Pharmaceuticals Q2 loss per share $0.08
August 04, 2016 at 07:53 AM EDT
* Progenics Pharmaceuticals announces second quarter 2016 financial and business results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.